- Home
- RIGL vs MSC Comparison
RIGL vs MSC Comparison
Compare RIGL & MSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RIGL | MSC |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 628.4M | 562.4M |
| IPO Year | 2000 | 2017 |
Fundamental Metrics
Financial Performance| Metric | RIGL | MSC |
|---|---|---|
| Price | $25.93 | $2.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $45.67 | N/A |
| AVG Volume (30 Days) | ★ 365.0K | 1.6K |
| Earning Date | 03-03-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1867.68 | N/A |
| EPS | ★ 19.48 | N/A |
| Revenue | ★ $294,282,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.23 | N/A |
| P/E Ratio | $1.34 | ★ N/A |
| Revenue Growth | ★ 64.15 | N/A |
| 52 Week Low | $15.50 | $2.50 |
| 52 Week High | $52.24 | $6.63 |
Technical Indicators
Market Signals| Indicator | RIGL | MSC |
|---|---|---|
| Relative Strength Index (RSI) | 27.05 | 31.38 |
| Support Level | $18.14 | N/A |
| Resistance Level | $31.26 | $3.26 |
| Average True Range (ATR) | 1.39 | 0.18 |
| MACD | -0.19 | -0.04 |
| Stochastic Oscillator | 10.63 | 13.46 |
Price Performance
Historical ComparisonAbout RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.